1 not yet recruiting, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow IgA Nephropathy: new trials by email Literature Review of IgA Nephropathy trials Research Report on IgA Nephropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. RD06-05 CART Cell Injection - SLE, LN | Early Phase 1 | Recruiting | Nanjing Bioheng Biotech Co., Ltd. | 96 | 2025-07-24 | 2026-08-03 |
| IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients IM19 chimeric antigen receptor T cell injection - IgA Nephropathy, Membranous Nephropathy | Early Phase 1 | Not yet recruiting | Beijing Immunochina Medical Science & Technology Co., Ltd. | 12 | 2024-12-13 | 2024-11-26 |
Glomerulonephritis, IGA (2) · Anti-Glomerular Basement Membrane Disease (1) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Glomerulonephritis, Membranous (1)
Autoimmune Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glomerulonephritis (2) · Immune System Diseases (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Cardiovascular Diseases (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Respiratory Tract Diseases (1) · Skin Diseases (1)
Beijing Immunochina Medical Science & Technology Co., Ltd. (1) · Nanjing Bioheng Biotech Co., Ltd. (1)
China (1)